Key result
Physiology-guided management of coronary microvascular dysfunction improves angina symptoms and quality of life in INOCA patients, though its impact on hard clinical endpoints remains unestablished.
Why the study?
The prognostic effect of physiology-driven management of coronary microvascular dysfunction among patients with angina and ischemic heart disease remains debated and represents an unmet clinical need.
Does invasive physiology-guided assessment and management of coronary microvascular dysfunction improve symptoms and clinical prognosis in patients with ischemic heart disease and INOCA?
Does invasive physiology-guided assessment and management of coronary microvascular dysfunction improve symptoms and clinical prognosis in patients with ischemic heart disease and INOCA?
Answers are grounded in this paper and cite their sources.
Invasive physiological assessment of the coronary microvasculature enables tailored therapy that improves angina symptoms and quality of life in INOCA patients, though further randomized trials are needed to establish benefits on hard clinical outcomes.
The critical role of the coronary microvascular compartment and its invasive functional assessment has become apparent in light of the significant proportion of patients presenting signs and symptoms of myocardial ischemia, despite the absence of epicardial disease, or after the adequate treatment of it. However, coronary microvascular dysfunction (CMD) represents a diagnostic challenge because of the small dimensions of the coronary microvasculature, which prevents direct angiographic visualization. Several diagnostic tools are now available for the invasive assessment of the coronary microvascular function, which, in association with the physiological indices used to investigate the epicardial department, may provide a comprehensive evaluation of the coronary circulation as a whole. Recent evidence suggests that the physiology-guided management of CMD, although apparently costly and time-consuming, may offer a net clinical benefit in terms of symptom improvement among patients with angina and ischemic heart disease. However, despite the results of several observational studies, the prognostic effect of the physiology-driven management of CMD within this population is currently a matter of debate, and therefore represents an unmet clinical need that urgently deserves further investigation.
No takes yet. Share an insight, caveat, or question.
Mangiacapra et al. (2021) conducted a review in Coronary microvascular dysfunction (CMD) and ischemia with nonobstructive coronary arteries (INOCA). Invasive physiological assessment of coronary microvascular function (CFR, IMR, HMR, mMR, RRR, MRR, continuous thermodilution, acetylcholine testing) was evaluated on Symptom improvement (angina severity and quality of life) and hard clinical prognostic endpoints. Physiology-guided management of coronary microvascular dysfunction improves angina symptoms and quality of life in INOCA patients, though its impact on hard clinical endpoints remains unestablished.
Synapse has enriched 10 related papers. Consider them for comparative context: